• May 20, 2022

    Eastern Health, Newfoundland has a vacancy for a RADIOCHEMIST (UNDER CLASSIFICATION REVIEW) PET/CT Facility Diagnostic Imaging Program – Molecular Imaging (Nuclear Medicine) Permanent, Full-Time Apply online at Upon successfully applying for a vacancy then you will receive a confirmation email. If you do not receive this email please contact Recruitment 777-7777 ext 5-2 immediately To […]

    Read More
  • April 22, 2022
    11th International Conference on Isotopes (11ICI) Webinar Series April 28, 2022

    You are invited to attend the 11th International Conference on Isotopes (11ICI) Webinar Series organized by Sylvia Fedoruk Canadian Centre for Nuclear Innovation in partnership with the University of Saskatchewan and Tourism Saskatoon. Webinar Series 1 of 4 Demand and Supply of Isotopes Around the World – From Diverse Perspectives April 28, 2022 *7:00 AM […]

    Read More
  • January 26, 2022
    Alert: HFR Outage Will Impact Isotope Supply

    NMEU COMMUNICATION 24 JAN 2022 Z January 26, 2022 On January 24, the Emergency Response Team (ERT) of Nuclear Medicine Europe (NMEu) communicated that there will be a delay in the restart of the HFR Reactor that will impact the supply of Mo-99 and Lu-177 in coming weeks. The delay is due to discovery of […]

    Read More
  • January 28, 2021
    CARS Newsletter Winter 2021

    Find the latest news in our community on CARS Newsletter January 2021.

    Read More
  • October 7, 2020
    Update – Calgary Radiopharmaceutical Centre announces availability of DISIDA kits

    Dear colleagues, The Calgary Radiopharmaceutical Centre (CRC) is addressing the shortage of Mebrofenin kits. CRC announces the availability for distribution of Stannous DISIDA Kits used in hepatobiliary imaging. For information regarding orders send your request to, For details please contact: Ingrid Koslowsky, Director Calgary Radiopharmaceutical Centre Foothills Medical Centre 1433-29 St W Calgary, Alberta, Canada […]

    Read More
  • June 17, 2020
    Mandatory Regulatory Enrolment Process, Effective October 01, 2020

    On March 30, 2020, Health Canada published a Notice communicating that the use of the Regulatory Enrolment Process (REP) will be mandatory as of October 1, 2020, for pharmaceutical, biologic and radiopharmaceutical drugs for human use as well as disinfectants, pursuant to Part C, Division 1 and Division 8 of the Food and Drug Regulations. […]

    Read More

Join us as a member

Filled out our membership form and join CARS Membership today for more radiopharmaceutical and scientific knowledge.